Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinomaZhongjie Li, Guo‐Dong Lu|Acta Pharmacologica Sinica|2020Cited by 300
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinomaFeng Ji, Guo‐Dong Lu|Acta Pharmacologica Sinica|2020Cited by 161
Fatty acid activation in carcinogenesis and cancer development: Essential roles of long‑chain acyl‑CoA synthetases (Review)Yue Tang, Guo‐Dong Lu|Oncology Letters|2018Cited by 154
Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagyJing Zhou, Guo‐Dong Lu|Experimental & Molecular Medicine|2022Cited by 35
Rab7/Retromer‐based endolysosomal trafficking is essential for proper host invasion in rice blastXin Chen, Wenhui Zheng, Lili Lin et al.|New Phytologist|2023Cited by 33